All Things Policy: To Gene Or Not To Gene

Shambhavi Naik, Yazad Jal and Anirudh Kanisetti discuss the contentious issue of germline gene editing.
Eminent scientists have called for a five year moratorium on clinical applications of germline (concerning reproductive cells) gene editing. Such a move will reduce funding and transnational research in congenital diseases.
In this episode, they discuss how proposing stringent safety standards would be more effective than an outright ban.

Subscribe and listen to the podcast on:

iTunes

Castbox

Google Podcasts

Spotify

or any other podcast app.